Things to Know about Pramiracetam
Pramiracetam is a synthetic derivative of the first lab manufactured nootropic i.e. piracetam, but happens to be more potent. Pramiracetam has been the subject of numerous tests for discovering ways of treating memory loss and cognitive problems associated with brain injury and Alzheimer's disease as well as treating different central nervous system disorders. It has been clinically proven to boost cognition in young adults suffering from memory problems as well as improving memory in healthy, elderly adults suffering from memory loss. Students seeking to enhance their mental abilities can be happy that anecdotal evidence suggests Pramiracetam is effective in optimising overall brain function and increasing productivity and focus. In the US, the USFDA has not approved Pramiracetam for any specific use, meaning it is unregulated and can be legally purchased and used.
Pramiracetam can be classified as a nootropic, created with the specific aim of enhancing overall cognition, with benefits such as; improve learning capacity, improved memory, dementia treatment and social fluency just to name a few.
Pramiracetam has been proven to be effective in enhancing memory, as revealed through years of extensive tests conducted on both animals and young adults suffering from cognitive impairment caused by brain injuries. By acting as an effective anti-amnesic and stimulating the hippocampus i.e. the section of the brain responsible for creating new memories, Pramiracetam is effective in reducing forgetfulness, and overall improving memory. Through dual action, Pramiracetam is effective in boosting memory, with many users claiming that their speed of recall has improved tremendously, a claim that can be backed by animal studies.
Pramiracetam has a reputation for overall cognitive enhancement by increasing alertness and expanding learning capacity, making it famous among students seeking a good study aid. Studies conducted on animals revealed that Pramiracetam is a great contributor of the memory improvement and learning mechanisms by increasing activity in the hippocampus.
Trials conducted on individuals with primary degenerative dementia reveal that Pramiracetam reversed amnesia, consequently reducing forgetfulness and enhancing recall. Other studies that gauged the effects of racetam nootropics including Pramiracetam on patients suffering from mild-moderation dementia, indicated that there were significant improvements in memory and cognition. The ability of the nootropic to enhance existing neurotransmitters can explain the results achieved in part. While not approved as a treatment for Alzheimer's disease in the US, Pramiracetam often gets prescribed in Europe as a treatment for dementia, cognitive issues associated with Alzheimer's disease as well as other neurological disorders.
Even though no documented research on the effects of Pramiracetam on social fluency exists, most users report increased conversational creativity and social fluency.